BRAF and differentiated thyroid carcinoma: Therefore, in this study, we aim to investigate the association between BRAF V600E and TERT mutations, the loss of radioiodine avidity, and the clinical characteristics as well as their diagnostic and prognostic value in Vietnamese patients with radioiodine-refractory differentiated thyroid cancer (RAIR-DTC).